157 related articles for article (PubMed ID: 37051625)
1. Research on Predicting the Occurrence of Hepatocellular Carcinoma Based on Notch Signal-Related Genes Using Machine Learning Algorithms.
Zhou D; Cao S; Xie H
Turk J Gastroenterol; 2023 Jul; 34(7):760-770. PubMed ID: 37051625
[TBL] [Abstract][Full Text] [Related]
2. Machine learning algorithm and deep neural networks identified a novel subtype in hepatocellular carcinoma.
Zi Q; Cui H; Liang W; Chi Q
Cancer Biomark; 2022; 35(3):305-320. PubMed ID: 36373311
[TBL] [Abstract][Full Text] [Related]
3. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
4. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
Front Immunol; 2021; 12():653836. PubMed ID: 33897701
[No Abstract] [Full Text] [Related]
5. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
[TBL] [Abstract][Full Text] [Related]
6. The integration of machine learning and multi-omics analysis provides a powerful approach to screen aging-related genes and predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
Shen J; Gao H; Li B; Huang Y; Shi Y
Aging (Albany NY); 2023 Jul; 15(14):6848-6864. PubMed ID: 37517087
[TBL] [Abstract][Full Text] [Related]
7. Identification of Biomarkers Related to Immune Cell Infiltration in Hepatocellular Carcinoma Using Gene Co-Expression Network.
Zhou W; Chen Y; Luo R; Li Z; Jiang G; Ou X
Pathol Oncol Res; 2021; 27():601693. PubMed ID: 34257558
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis of pyroptosis regulation patterns and characterization of tumor microenvironment in patients with hepatocellular carcinoma.
Shang B; Wang R; Qiao H; Zhao X; Wang L; Sui S
PeerJ; 2023; 11():e15340. PubMed ID: 37193028
[TBL] [Abstract][Full Text] [Related]
9. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
Yu ZL; Zhu ZM
Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
[TBL] [Abstract][Full Text] [Related]
11. Machine-learning algorithms based on personalized pathways for a novel predictive model for the diagnosis of hepatocellular carcinoma.
Cheng B; Zhou P; Chen Y
BMC Bioinformatics; 2022 Jun; 23(1):248. PubMed ID: 35739471
[TBL] [Abstract][Full Text] [Related]
12. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract][Full Text] [Related]
13. Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma.
Sun L; Wu Z; Dong C; Yu S; Huang H; Chen Z; Wu Z; Yin X
BMC Med Genomics; 2023 Jun; 16(1):130. PubMed ID: 37316840
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
[TBL] [Abstract][Full Text] [Related]
15. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
16. Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients.
Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Gao W; Yu X
Int J Biol Sci; 2022; 18(1):360-373. PubMed ID: 34975338
[TBL] [Abstract][Full Text] [Related]
17. Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The Cancer Genome Atlas database.
Zhao X; Dou J; Cao J; Wang Y; Gao Q; Zeng Q; Liu W; Liu B; Cui Z; Teng L; Zhang J; Zhao C
Oncol Rep; 2020 Jun; 43(6):1771-1784. PubMed ID: 32236623
[TBL] [Abstract][Full Text] [Related]
18. Machine learning-based prognostic modeling of lysosome-related genes for predicting prognosis and immune status of patients with hepatocellular carcinoma.
Li W; Wang Q; Lu J; Zhao B; Geng Y; Wu X; Chen X
Front Immunol; 2023; 14():1169256. PubMed ID: 37275878
[TBL] [Abstract][Full Text] [Related]
19. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
20. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
Front Immunol; 2022; 13():990790. PubMed ID: 36248822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
